Library

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 4-demethoxydaunorubicin  (1)
  • BVDV  (1)
  • Gd-DTPA-delayed enhancement  (1)
  • 1
    Electronic Resource
    Electronic Resource
    Signalintensitätsbeurteilung motilitätsgestörter Myokardareale in MR-Spätaufnahmen nach Gabe von Gd-DTPA (2000)
    Springer
    Der Radiologe 40 (2000), S. 150-154 
    Details
    ISSN: 1432-2102
    Keywords: Schlüsselwörter ; Herz ; MR ; Herzinfarkt ; Vitalitätsdiagnostik ; Gd-DTPA-Spätaufnahmen ; Key words ; Heart ; MR ; Myocardial infarction ; Myocardial viability ; Gd-DTPA-delayed enhancement
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Purpose: The aim of the study was to correlate delayed contrast enhancement of dysfunctional regions of the myocardium after injection of Gd-DTPA with the improvement of regional contractility 3 months after revascularization. Material and methods: Eleven patients with coronary artery disease and wall motion abnormalities underwent MR imaging before and 3 months after revascularization therapy (PTCA or CABG). Short-axis images were acquired using a cine gradient echo sequence. After revascularization, a representative slice was analyzed 14±1 min after injection of 0.1 mmol/kg Gd-DTPA using a T1-weighted turbo fast low-angle shot sequence. Improved systolic wall thickening 3 months after revascularization served as criterion of viability and was correlated with delayed contrast enhancement patterns. Results: After revascularization, 6 patients showed complete recovery of the dysfunctional area, 1 patient partial recovery, and 4 patients remained unchanged. All 4 patients with persisting wall motion abnormalities, 1/6 patients with recovery and the patient with partial recovery revealed a delayed enhancement. Conclusions: Three months after revascularization, delayed enhancement of dysfunctional myocardium is evident in patients without regional wall motion improvement, while the lack of delayed enhancement correlates with improvement of regional contractility.
    Notes: Zusammenfassung Zielsetzung: Die Korrelation der Signalintensität motilitätsgestörter Myokardareale in Spätaufnahmen nach der Gabe von Gd-DTPA mit der Erholung der regionalen Funktion nach Revaskularisierung sollte untersucht werden. Material und Methode: 11 Patienten mit Koronararterienstenosen und Wandbewegungsstörungen wurden mit einer CINE-GRE-Sequenz in der kurzen Herzachse vor und 3 Monate nach Revaskularisierung (PTCA oder Bypassoperation) untersucht. Bei der Kontrolle wurde eine repräsentative Schicht im motilitätsgestörten Areal 14±1 min nach der Gabe von 0,1 mmol/kg Gd-DTPA mit einer T1-w-TurboFLASH-Sequenz untersucht. Eine regionale Kontraktilitätsverbesserung wurde als vermehrte systolische Wanddickenzunahme nach Revaskularisierung definiert und mit der Signalintensität in Spätaufnahmen korreliert. Ergebnisse: Bei 6 Patienten erholte sich nach Revaskularisierung das gesamte motilitätsgestörte Areal, bei 1 Patienten partiell, bei 4 Patienten blieben die Wandbewegungsstörungen unverändert. Bei 4/4 Patienten mit persistierenden Wandbewegungsstörungen, bei 1/6 Patienten mit erholtem Myokard sowie bei dem Patienten mit dem partiell erholten Areal war ein spätes Enhancement nachweisbar. Schlussfolgerungen: Ein Enhancement von Myokardarealen in Spätaufnahmen nach der Gabe von Gd-DTPA 3 Monate nach der Revaskularisierung ist bei persistierenden Wandbegungsstörungen zu beobachten, wogegen das Fehlen eines späten Enhancements mit einer Verbesserung der regionalen Wandfunktion korreliert.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/s001170050024
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 2
    Electronic Resource
    Electronic Resource
    Phase I study of oral idarubicin given with a weekly schedule (1986)
    Springer
    Investigational new drugs 4 (1986), S. 31-38 
    Details
    ISSN: 1573-0646
    Keywords: idarubicin ; 4-demethoxydaunorubicin ; anthracycline ; anticancer agent ; phase I study
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary Thirty one patients with solid tumors were entered into a phase I trial with idarubicin, a new anthracycline antibiotic with oral antitumor activity in animals. The drug was scheduled to be given for 4 consecutive weeks at doses ranging from 10 to 20 mg/m2. Leukopenia was the dose-limiting toxicity. Thrombocytopenia was occasionally seen. Since several patients could not receive the third and fourth administrations of the drug at 17.5 and 20 mg/m2, higher doses were administered only for 2 consecutive weeks. With this schedule, the maximum tolerated dose was 25 mg/m2 and leukopenia was again the dose-limiting toxicity. With both schedules, myelosuppression was highly variable and could not be related to prior therapy, bone or liver metastases, or performance status. Other toxicities were mild to moderate and were dominated by nausea and vomiting which were observed in 29% of the patients. Alopecia and mucositis were unfrequent and cardiac toxicity was not observed. Starting doses of 15 mg/m2 for 4 consecutive weeks or 20 mg/m2 for 2 consecutive weeks could be proposed for oral phase II studies with idarubicin, under careful pharmacokinetic monitoring.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00172013
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 3
    Electronic Resource
    Electronic Resource
    A Universal `One-tube' RT-PCR Protocol for Amplifying Isolates of Bovine Viral Diarrhoea Virus (2000)
    Springer
    Veterinary research communications 24 (2000), S. 491-503 
    Details
    ISSN: 1573-7446
    Keywords: bovine viral diarrhoea ; BVDV ; diagnosis ; genome ; genotype ; methodology ; polymerase chain reaction ; primers ; reverse transcription ; virus
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The increase in the knowledge of the genetic variability of BVDV and the identification of some of the genetic determinants of its pathogenicity require robust and practical tools for rapid molecular characterization of the various genotypes of this virus. This study was undertaken to develop a standard protocol for RT-PCR that allows the amplification of various parts of the genome of BVDV without the need for optimizing each individual reaction. The reaction set-up is very flexible because it consists of two pre-mixes. These are a master mix, with all the required reagents except the desired primers, which are the components of the second pre-mix and are therefore easily interchangeable between the different reactions. After adding any primer-containing pre-mix to the fixed master mix, a non-interrupted cycling protocol led to the generation of amplicons of up to 4 kbp in size in amounts sufficient for subsequent sequencing reactions. The method was applied to five different regions of the BVDV genome: (i) the well-known 5′-UTR to differentiate genotypes I and II; (ii) the entire E2 gene, or an approximately 550 bp region within the E2 gene, in order to find the molecular equivalent of antigenic varieties; (iii) the entire structural protein coding region covering the Npro, capsid, E RNS, E1 and E2 genes; (iv) a 2.1 kbp region embracing the NS2/3 junction which is known to be cleaved in cytopathic biotypes of BVDV; and (v) the region covering the entire NS4B and NS5A/B genes. All six RT-PCRs were successfully applied using (i) primers with lengths of between 20 and 52 nucleotides, (ii) an aliquot of RNA extracted from either 106 infected bovine embryonal lung cells or the same number of leukocytes from viraemic cattle, and (iii) all the genotype I and II strains of BVDV tested. The technique described was used to generate various Sindbis virus/BVDV recombinants. The correct processing of the amplicon-derived E2 glycoprotein of BVDV strain PT810 was demonstrated by its reaction with a monoclonal antibody in an immunofluorescence assay. Given the variety of RT-PCRs tested, we conclude that this universal protocol may be useful with other RNA viruses.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1023/A:1006407807133
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...